MOL ECULAR PR OPERTIES O PTIMIZATION PROJECT |
Property-Based
Drug design
The creation of stable predictable models for different properties and activities.
Lipophilicity
1995 [1]:
logP= -0.22 +0.033 MV -0.99 SCa -0.13 SCd
n=38, r=0.964, s=0.37
where MV is molecular volume, Ca is free energy H-bond acceptor factor, Cd is free energy H-bond donor factor.
1997 [2]:
logP= -0.01+0.249 a -0.68 SCa
n=234, r=0.961, s=0.34
where a is molecular polarizability
2000 [3,4]
logP= 0.266 a -1.00 SCa(o)
n=2850, r=0.970, s=0.23
where Ca(o) is overall free energy H-bond acceptor factor
2001 [5]:
N
logPi = S [((logPj + 0.267(ai - a j) - 1.00 (∑Ca(o)i -∑Ca(o)j)]/N
j=1
n=138, r=0.981, s=0.29, F= 3431
where index i indicates the compound-of-interest, index j indicates a near neighbor; and N is the number of closely related structures used.
2002 [6]:
N
logPi = S [((logPj + 0.267(ai - a j) - 1.00 (∑Ca(o)i -∑Ca(o)j)]/N
j=1
n=10937, r=0.972
References:
Raevsky,
O.A., Schaper, K.-J., Seydel, J.K.,
H-Bond Contribution to Octanol-Water Partition Coefficients of Polar
Compounds, Quant. Struct.-Act.Relat., 1995,
14, 433.
Raevsky,
O.A., Quantification
of Non-Covalent Interactions on the Basis of the Thermodynamic Hydrogen Bond
Parameters, J.Phys.Org.Chem., 10,
405-413 (1997).
Raevsky,
O.A., Schaper, K.-J., Waterbeemd, H. and McFarland J.W.,
Hydrogen Bond Contributions to Properties and Activities of Chemicals and
Drugs, In Molecular modeling and
prediction of bioactivity; Guntertofte, K. and Jorgensen, F.S., Eds.;
Kluwer Academic/Plenum Publishers: New York, 2000,
pp.221-227.
Raevsky, O.A., Trepalina, E.P., Trepalin, S.V., ibid,
pp. 489-490.
Raevsky,
O.A.,
Molecular Lipophilicity Calculations of Chemically Heterogeneous Chemicals
and Drugs on the Basis of Structural Similarity and Physicochemical
Parameters, SAR and QSAR in Environ.
Res., 2001, 12, 367-381
(2001).
Raevsky,
O.A., Trepalin, S.V., Trepalina, E.P., Gerasimenko, V.A. and Raevskaja, O.E.,
SLIPPER-2001 – Software for Predicting Molecular Properties on the Basis
of Physicochemical Descriptors and Structural Similarity, J.Chem.Inf.Comput.Sci.,
42, 540-549 (2002).
Solubility
in water
Vapours
Solubility in Water
2003 [1]:
logLw=-0.052 a + 1.73 SCa(o) - 0.82 SCd
n=426, r= 0.922, rcv= 0.920, s=0.84
logLw=-0.031
a
+ 1.64 SCa(o)
- 0.98 SCd
- 1.39 HCA - 1.53 Amine - 0.78 CX3 + 1.71 Amide
-
1.05 Ether + 1.09 ArNO2 - 0.78 IHB
n=426,
r=0.964, q2=0.960, s=0.58
1997,
[2]:
log 1/S=-0.42 + a - SCa(o) +SCd
n=45, r= , s=, F=
2000, [3]:
log 1/S=-0.42 + a - SCa(o) + SCd
n=142, r=, s=, F=
2003, [4]:
logS = 0.434 –0.298 a +1.090 SCa(o) +0.304½SCd½
n = 629
r = 0.947 s = 0.536 q
= 0.945
logS = 0.514 -0.277 a +0.884 SCa(o) +0.352½SCd½ +0.350 N(cycl) –1.221 I(alk)
–0.357 I(CX3) +0.237
I(base) –0.473 I(RCOOH) –0.727 I(HBintra)
n
= 629 r = 0.970
s = 0.408 q = 0.968
logS =
0.523 -0.274 a
+0.882 SCa(o)
+0.318½SCd½
+0.400 N(cycl) -1.367 I(alk)
-0.433 I(CX3) +0.225
I(base) -0.423 I(RCOOH) -0.558 I(HBintra)
n
= 787 r = 0.967 s = 0.467 q
= 0.966
Solids
Solubility
2000, [3]:
logS = -0.39 –0.233 a +0.65 SCa(o) +0.13½SCd½
n=70, r=0.937, s=0.38, F=159.0
2002, [5]:
N
logSi = S [((logSj - 0.275(ai - a j) + 0.96 (Cai -Caj) –0.27(Cdi -Cdj)]/N
j=1
n=42, r=0.931, s=0.48
References:
Intestinal
Absorption in
Human.
Passively
transported drugs
2000 [1]:
FA=1/(1+10
–[5.05 - 0.36 åCa
+ 0.26 åCd)]
N=31,
r=0.974, s=0.09, Q=0.959
2003:
FA=1/(1+10
–[2.20 - 0.016 (WFEASA+WFEDSA)]
N=154,
r=0.910, s=0.15 , F=738.5
where OFEASA and OFEDSA are 3D H-bond descriptors (see HYBOT)
Drugs
with possible different mechanisms of
absorption
2002
[2]:
FA=1/(1+10[(-log(FAnrs/(1-FAnrs))- 0.36DåCa(drug-nrs)+
0.26 DåCd(drug-nrs)]) (23)
n=100, r=0.945, s=0.11, Q=0.943
References:
Raevsky, O.A., Fetisov, V.I., Trepalina, E.P., McFarland J.W and Schaper, K.-J., Quantitative estimation of drug absorption in humans for passively transported compounds on the basis of their physicochemical parameters, Quant. Struct.-Act.Relat., 2000, 19, 366-374.
Raevsky, O.A., Schaper, K.-J., Artursson, P., and McFarland, J.W., A Novel Approach for Prediction of Intestinal Absorption of Drugs in Human Based on Hydrogen Bond descriptors and Structural Similarity, Quant. Struct.-Act.Relat., 2002, 21, 402.